Analyst Ratings for Apogee Therapeutics Inc (APGE)
APGE Rating Summary
APGE Price Target Summary
- Highest: $160.00 (Guggenheim)
- Lowest: $81.00 (Truist Securities)
- Average: $117.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$117.88 (+30.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$117.88 (+30.4%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/1/2026 | Rothschild Redburn | Qize Ding | New Coverage | Buy (N/A) |
140.00 (N/A) |
82.03 (90.38) |
10.18% | Details |
| 3/17/2026 | Truist Securities » Updated 5/27/2026 |
Danielle Brill | New Coverage | Hold (N/A) |
81.00 (83.00) |
71.09 (90.38) |
27.13% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
